Search - tctmd.com

Displaying 501 - 520 of 722

Sort: Relevancy | Date

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Conference News ESC 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Todd Neale

September 08, 2014

News Conference News ESC 2014

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

Todd Neale

September 01, 2014

News Industry News

Kona Medical Initiates Clinical Trial of Non-Invasive Therapy for Resistant Hypertension

August 27, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Daily News

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

Yael L. Maxwell

June 11, 2014

News Daily News

SYMPLICITY HTN-2: La Denervación Renal es Segura y Eficaz a los 3 Años

Yael L. Maxwell

June 11, 2014

Presentation

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

Presenter: Murray D. Esler

June 10, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Industry News

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014

Presentation EuroPCR 2014

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

News Industry News

Medtronic Announces CE Mark and Launch of NC Euphora(TM) Coronary Balloon

May 20, 2014

News Daily News

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

May 12, 2014

Presentation

Eligibility for Renal Denervation: Experience at 11 European Expert Centers

Presenter: A. Persue

May 12, 2014

News Daily News

Renal Denervation Shows Promise in Patients Refractory to Stenting

L.A. McKeown

May 02, 2014

$Renal Denervation for Hypertension Refractory to Renal Artery Stenting$

Presentation

Renal Denervation for Hypertension Refractory to Renal Artery Stenting

Presenter: Yvonne Bausback

May 02, 2014

Presentation

ACC 2014 Late Breaking Trials Renal Denervation for Resistant Hypertension

Presenter: Gregg W. Stone

April 28, 2014

Advertisement

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

Kona Medical Initiates Clinical Trial of Non-Invasive Therapy for Resistant Hypertension

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

SYMPLICITY HTN-2: La Denervación Renal es Segura y Eficaz a los 3 Años

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Medtronic Announces CE Mark and Launch of NC Euphora(TM) Coronary Balloon

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

Eligibility for Renal Denervation: Experience at 11 European Expert Centers

Renal Denervation Shows Promise in Patients Refractory to Stenting

Renal Denervation for Hypertension Refractory to Renal Artery Stenting

ACC 2014 Late Breaking Trials Renal Denervation for Resistant Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content